Sector consensus WuXi AppTec Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 05/03/2026			5-day change	1st Jan Change
92.45 ^CNY	+0.47%		-5.67%	+2.00%

04/03	JPMorgan Chase's long position in H-shares of Wuxi Apptec increases to 8.32% on Feb 26 from 7.14%, HKEX shows	RE
20/02	BlackRock's long position in H-shares of Wuxi Apptec decreases to 4.51% on Feb 16 from 5.22%, HKEX shows	RE

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
WUXI APPTEC CO., LTD.			CN¥133.13	+44%	18
ARGENX SE			€835.07	+33.4%	15
INSMED INCORPORATED			$212.53	+48.03%	19
BIONTECH SE			$118.24	+34.49%	19
WUXI BIOLOGICS (CAYMAN) INC.			HK$39.84	+27.9%	23
GENMAB A/S			DKK 2,237.63	+26.06%	14
SUMMIT THERAPEUTICS INC.			$23.49	+110.1%	13
AKESO, INC.			HK$153.88	+70.84%	21
EXELIXIS, INC.			$46.83	+13.45%	18
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			HK$536.92	+45.19%	17
MADRIGAL PHARMACEUTICALS, INC.			$667.57	+51.95%	14
IMMUNITYBIO, INC.			$15.25	+70.2%	4
ARROWHEAD PHARMACEUTICALS, INC.			$81.36	+27.93%	11
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	₩7,70,000	+37.25%	1
VAXCYTE, INC.			$109	+87.12%	9
NUVALENT, INC.			$143.53	+43.34%	17
PHARMAESSENTIA CORPORATION			NT$753.19	+9.32%	7
CYTOKINETICS, INCORPORATED			$91.17	+46.59%	18
BELITE BIO, INC			$211.5	+22.56%	8
BIOCON LIMITED			₹422.84	+9.32%	19
Average			38,841.65	+42.95%	14
Weighted average by Cap.			24,139.27	+42.09%	16